 use FDG-PET detection management malignant lymphoma correlation uptake prognosis patients untreated malignant lymphoma head neck region positron emission tomography PET FDG SPECT imaging Tumor-to-normal soft-tissue contrast ratios TCRs min injection FDG malignant lymphomas patients poor prognosis TCRs glucose utilization rates GURs low TCR GUR patient low-grade malignancy comparison scintigraphy patients high TCRs GURs likely increased accumulation accumulation much FDG poor prognostic patients FDG-PET useful detection management malignant lymphoma